In this webinar, Biogen, and their partner IPM.ai, will discuss how leveraging machine learning and artificial intelligence can help improve trial recruitment.

Whether it’s selecting possible location sites, expanding the list of physicians who treat the disease (vs. focusing only on a smaller subset like your target list), utilizing de-identified longitudinal claims and cutting edge machine learning techniques puts Biogen at the forefront for their clinical trial recruitment efforts.

In the wake of the COVID-19 crisis, the healthcare industry has been forced to embrace this new normal by adjusting both its mindset and its messaging in order to stay connected with patients and engaged with HCPs. In addition to anticipating patients’ constantly emerging needs, industry experts must also find ways to engage with patients and HCPs remotely, yet authentically, by adopting solutions and innovations that cater toward more personalized and pre-emptive types of care and treatment.

Join us for this pre-conference webcast to get a sneak peek into the cutting-edge educational content that our high-level speakers will be discussing during the conference, specifically some of the ways the coronavirus response has pushed the adoption and access curve for telemedicine and altered the course of healthcare communications.

As HCPs work hard to contain the spread of COVID-19, maintaining the flow of information between pharma and physicians becomes increasingly vital, with medical marketers being tasked to ensure therapeutic communication isn’t compromised.

This virtual event will provide our partners with a platform to showcase their capabilities and offerings that can be beneficial to healthcare professionals during these difficult times. MM&M’s editorial team and industry experts will discuss the impact of the COVID-19 pandemic on the healthcare industry, and where we go from here.

In this webinar Web Sun, President and Co-Founder of Komodo Health will discuss how Medical Affairs can continue to be successful during the pandemic, as well as share opportunities for how to best prepare for success in a post COVID-19 market.

With healthcare on the front lines of the COVID-19 pandemic, the ways in which we communicate have been drastically altered, and finding new ways to connect with patients and providers has become paramount. In the face of this new communication landscape, companies are looking to do more with less, embracing flexibility and the power of digital tools to keep vital health and treatment information flowing.

Within our current climate, opening the lines of communication has become more important than ever before. Companies must be quick to adapt to the “new normal” brought on by the COVID-19 pandemic or be left behind.

MM&M Convene is our way of helping our partners adapt to the drastically accelerated shift to virtual communication, by providing a platform to showcase companies’ capabilities, expertise and offerings that can be beneficial to healthcare industry professionals during these difficult times and beyond.

Pharma marketing has come a long way, however the art of managing a brand’s share of voice in this modern landscape of constrained resources and diminished in-person access to healthcare providers (HCPs) continues to be a work in progress. In response, a vast majority of marketing managers have moved from a traditional rep-centric model to non-personal promotion (NPP), with a major focus on digital advertising.

During this webinar, Becky Chidester, Dr. Destry Sulkes, Mark Truss and Nichole Davies of Wunderman Thompson Health will: unveil findings from the third annual Wunderman Thompson Health Inertia Study, discuss the steps healthcare brands can take to leverage behavioral economics and research insights to develop high-impact, personalized creative content, share how brands can use data and technology to create streams of dynamic content that expose the right messages to the right audiences at the right times to inspire action.

In this webinar, we will discuss how audience targeting is changing with today’s heightened focus on privacy. How can pharma brands serve messaging to highly qualified consumers, while preserving the privacy of patients? The panel will discuss current approaches in the marketplace and the impact of the 2020 NAI guidelines on targeted health campaigns.

Marketers need to think beyond the traditional agency of record (AOR) partnership to a model that enables teams to crowdsource creative resources, accelerating timelines and increasing the quality of work. Find out how to effectively harness the power of creative crowdsourcing.

Lesley Foster with Swiss Precision Diagnostics GmbH (SPD) provides insights on how she implemented a terminology management program that resulted in less rework and significantly improved quality of SPD’s localized deliverables.

Today, regulators are shifting from document to data-based processes, using structured content as the source format for documentation ⁠— and receiving much attention.
In this webcast, we will explore various aspects of author engagement in structured content authoring.

This webcast will provide a fresh perspective and new insights using data points from our experience and recent research.

Join us to learn the latest market trends in access management as well as innovative solutions.

In this webcast, we will discuss some of the challenges of video localization and share standard practices in the creation of video content strategies for global audiences.

In this webinar, we will review different approaches to fraud detection, the subject of diagnostic testing, and if it’s best controlled through humans or artificial intelligence.